JG
Jeremy Grantham (GMO) disclosed increased in NEUROCRINE BIOSCIENCES INC
Jeremy Grantham (GMO) filed a 13F change in NEUROCRINE BIOSCIENCES INC (64125C109) on 2026-05-14, covering period end 2026-03-31.
Action
Increased
Capital
$3,681,696 reported value
Institutional 13F Signals1 evidence source
Why it matters
This signal is anchored to the SEC filing date while retaining the underlying 13F period end.